Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion01:15

Blood Transfusion

2.9K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.9K
Pharmacovigilance01:19

Pharmacovigilance

2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

12.4K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
12.4K
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

406
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
406
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

2.1K
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
2.1K
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

371
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
371

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reduction in Nuclear Size and Quadrupole Deformation of High-Spin Isomers of ^{127,129}In.

Physical review letters·2025
Same author

Injury Mechanisms in Mountain Biking: A Systematic Video Analysis of 534 Cases.

European journal of sport science·2025
Same author

Dietary intake remains unchanged while nutritional status improves in children and adults with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor.

Clinical nutrition (Edinburgh, Scotland)·2025
Same author

First Measurement of the Neutron-Emission Probability with a Surrogate Reaction in Inverse Kinematics at a Heavy-Ion Storage Ring.

Physical review letters·2025
Same author

Reduction of red blood cell transfusion with a patient blood management protocol in urological and visceral surgery: a before-after study.

Anaesthesia, critical care & pain medicine·2024
Same author

Self-inflicted crossbow injury in the head: A case report.

Journal of stomatology, oral and maxillofacial surgery·2023

Related Experiment Video

Updated: Apr 23, 2026

Rapid Fractionation and Isolation of Whole Blood Components in Samples Obtained from a Community-based Setting
11:31

Rapid Fractionation and Isolation of Whole Blood Components in Samples Obtained from a Community-based Setting

Published on: November 30, 2015

15.8K

[Postdonation information: the French fourth hemovigilance sub-process].

J-Y Py1, I Sandid2, S Jbilou3

  • 1EFS Centre-Atlantique, 14, avenue de l'Hôpital, 45072 Orléans cedex 2, France.

Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|October 6, 2014
PubMed
Summary

Postdonation information, crucial for blood product safety, is becoming France's fourth hemovigilance sub-process. Data reveals significant heterogeneity in managing this information, highlighting a need for standardized risk assessment.

Keywords:
HemovigilanceHémovigilanceInformation post-donLookbackPostdonation informationRappel

More Related Videos

Characterization of Leukocyte-platelet Rich Fibrin, A Novel Biomaterial
08:14

Characterization of Leukocyte-platelet Rich Fibrin, A Novel Biomaterial

Published on: September 29, 2015

12.6K
Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
09:41

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

Published on: March 5, 2020

9.1K

Related Experiment Videos

Last Updated: Apr 23, 2026

Rapid Fractionation and Isolation of Whole Blood Components in Samples Obtained from a Community-based Setting
11:31

Rapid Fractionation and Isolation of Whole Blood Components in Samples Obtained from a Community-based Setting

Published on: November 30, 2015

15.8K
Characterization of Leukocyte-platelet Rich Fibrin, A Novel Biomaterial
08:14

Characterization of Leukocyte-platelet Rich Fibrin, A Novel Biomaterial

Published on: September 29, 2015

12.6K
Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
09:41

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

Published on: March 5, 2020

9.1K

Area of Science:

  • Transfusion Medicine
  • Public Health
  • Regulatory Science

Background:

  • Postdonation information, defined as data about donors or donations after the event, poses challenges to blood product quality and safety.
  • Existing hemovigilance systems primarily focus on adverse events and do not fully encompass postdonation information management.
  • France is formalizing postdonation information as a distinct, fourth hemovigilance sub-process, building on over a decade of informal management.

Observation:

  • Analysis of 2013 French data, including regional notification and national reporting levels, indicates substantial heterogeneity in postdonation information management.
  • This variability appears largely driven by subjective differences in risk perception rather than objective criteria.
  • The current landscape reflects a decentralized approach to managing critical postdonation safety data.

Findings:

  • The implementation of postdonation information management in France shows significant variation across regions.
  • Subjective risk assessment is a primary contributor to the observed heterogeneity in handling postdonation information.
  • A lack of standardized protocols influences the consistency of hemovigilance practices.

Implications:

  • Formalizing postdonation information as a hemovigilance sub-process is essential for enhancing blood product safety.
  • Developing consensus and standardized guidelines for risk assessment is crucial to mitigate heterogeneity.
  • Future efforts should focus on objective criteria and collaborative work to ensure consistent and effective management of postdonation information.